Which statement describes the onset and duration of neuroleptic malignant syndrome after starting or changing therapy?

Which statement describes the onset and duration of neuroleptic malignant syndrome after starting or changing therapy?

• A. Slow onset (1-2 weeks after starting or changing therapy) and resolves within 9-14 days
• B. Rapid onset (within hours) and lasts 2 days
• C. Onset in months and persists for months
• D. Acute onset within 24 hours and resolves in 1 day

Answer: (A)

Neuroleptic malignant syndrome tends to develop after starting or increasing a neuroleptic, with onset over days to about two weeks, and then improve over the following days to a couple of weeks once the offending agent is stopped and supportive care is provided. The description of a slow onset around 1–2 weeks and a resolution in about 9–14 days fits this pattern best. This timing aligns with the typical clinical course, where symptoms such as fever, severe rigidity, autonomic instability, and altered mental status begin within that window and gradually improve after stopping the drug. The other timelines don’t match the usual course: onset within hours is too rapid for NMS and would more often point to other acute reactions; onset after months suggests tardive syndromes rather than NMS; onset within 24 hours with a one-day duration is not consistent with NMS’s progression and resolution.

Neuroleptic malignant syndrome tends to develop after starting or increasing a neuroleptic, with onset over days to about two weeks, and then improve over the following days to a couple of weeks once the offending agent is stopped and supportive care is provided. The description of a slow onset around 1–2 weeks and a resolution in about 9–14 days fits this pattern best. This timing aligns with the typical clinical course, where symptoms such as fever, severe rigidity, autonomic instability, and altered mental status begin within that window and gradually improve after stopping the drug. The other timelines don’t match the usual course: onset within hours is too rapid for NMS and would more often point to other acute reactions; onset after months suggests tardive syndromes rather than NMS; onset within 24 hours with a one-day duration is not consistent with NMS’s progression and resolution.